The table below shows Surgery Partners, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$274.30M
$300.10M
$293.80M
$158.80M
$87.10M
$246.90M
Capital expenditure
$78.70M
$90.40M
$88.80M
$80.60M
$57.60M
$42.90M
Investing cash flow
-$246.60M
-$488.50M
-$225.60M
-$307.90M
-$331.70M
-$88.40M
Dividends paid
-
-
-
-
-
SGRY operating cash flow (10-K history)
Surgery Partners, Inc. reported operating cash flow of $274.30M for fiscal year 2025. That is down 8.6% from $300.10M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $84.48M (FY 2015) to $274.30M. Figures come from the company's audited annual reports as filed with the SEC.
